Christopher J. Kirk
CIK 1744253 · CEO · last filed 2026-05-11
Christopher J. Kirk is a CEO who has filed 15 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for KZR, was dated May 11, 2026. Across all open-market trades the lifetime net is +$147.9K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
15
$147.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kezar Life Sciences, Inc. (KZR) Delisted | CEO | 0 | $7.29 | $0 | $147.9K | 15 | 2026-05-11 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | Kezar Life Sciences, Inc. (KZR) Delisted | Mixed | −43,134 | $0 | EDGAR |
| 2025-01-13 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-09 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-26 | Kezar Life Sciences, Inc. (KZR) Delisted | Mixed | — | $0 | EDGAR |
| 2023-07-24 | Kezar Life Sciences, Inc. (KZR) Delisted | Exer (M) | +48,950 | $44.1K | EDGAR |
| 2023-01-10 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | Kezar Life Sciences, Inc. (KZR) Delisted | Exer (M) | +33,060 | $29.8K | EDGAR |
| 2022-01-07 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-11 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-05 | Kezar Life Sciences, Inc. (KZR) Delisted | Buy (P) | +38,461 | $100.0K | EDGAR |